Stay updated on Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page
- Check6 days agoChange DetectedThe page version has been updated from v3.5.3 to v3.5.4, indicating a software update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3 on the study documents listed on the page, representing a newer version of the protocol/document referenced.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision tag now shows v3.5.2 instead of v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision history updated: added v3.5.0 entry and removed v3.4.3 entry.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No study data or user-facing content changes.SummaryDifference0.1%

- Check99 days agoChange DetectedA new site revision tag was added (Revision: v3.4.2) and the previous revision tag (v3.4.1) along with a government funding operating-status notice were removed.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.